Inhibrx Biosciences (INBX) Q2 2025 Earnings

14MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-3.6
39.43
82.45
125.48

Details

Expected EPS
-2.835
Actual EPS
-2.8
Surprise EPS
0.04
Surprise Percent
+1.23%

Description

Inhibrx Biosciences (INBX) has reported earnings of -2.8 per share for Q2 2025.

0 Comments

Share your thoughts